Skip to content
AnalystLens

Idex 8-K Report, Regulation FD Disclosure (Jul 23, 2024)

Reports
Regulation FD·Other Events·Exhibits & Filings
Filing Date
Filed July 23, 2024
Period End
July 23, 2024
Security
IEX
In the record · 2016–202610-K1110-Q338-K119

IEX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’18Jan ’18
  2. Material agreement8-K · Apr ’20Apr ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed July 23, 2024. Cited figures are marked; the original filing is the authoritative source.

IDEX Corporation (NYSE: IEX) has entered into a definitive agreement to acquire Mott Corporation and its subsidiaries from the Mott Corporation Employee Stock Ownership Trust, for cash consideration of $1 billiona, subject to customary adjustments.

Mott is described as a leading microfiltration business specializing in the design, customization, and manufacturing of sintered porous metal components and engineered solutions used in fluidic applications. Adjusted for the present value of expected tax benefits of approximately $100 millionb, the net transaction value is approximately $900 million, which the company says represents approximately 19x Mott's forecasted full year 2024 EBITDA and a mid-teens multiple based on forecasted 2025 EBITDA. IDEX expects Mott to generate approximately $200 million of revenue in 2024 with an EBITDA margin in the low 20s, and will fold it into its Health & Science Technologies segment.

The transaction is expected to be accretive to adjusted earnings per share in fiscal 2026 and to deliver a double-digit return on invested capital in year five after closing. Management frames the deal as an extension of its applied materials science portfolio, alongside the recently acquired Muon Group, Iridian Spectral Technologies, and STC Material Solutions, with target markets including semiconductor wafer fab equipment, energy transition, medical technologies, space and defense, and water purification. The transaction will be funded through cash on hand, borrowings under IDEX's current credit facility, and potential debt issuance, and is not subject to any financing conditions.

The company expects net leverage of approximately 1.8xc at closing. Closing is expected by the end of the third quarter of 2024, subject to regulatory approvals and customary closing conditions.

Key Highlights

  1. Acquisition of Mott Corporation for $1 billion in cash, subject to customary adjustments; net transaction value of approximately $900 million after present value of expected tax benefits of approximately $100 million.
  2. Valuation of approximately 19x Mott's forecasted full year 2024 EBITDA and a mid-teens multiple based on forecasted 2025 EBITDA.
  3. Mott expected to generate approximately $200 million of revenue in 2024 with an EBITDA margin in the low 20s; Mott has approximately 500 employees.
  4. Transaction expected to be accretive to adjusted EPS in fiscal 2026 and to deliver double-digit ROIC in year five post close; EBITDA margin expansion of approximately 400 to 600 basis points exiting 2026.
  5. Funded through cash on hand, credit facility borrowings and potential debt issuance, with net leverage of approximately 1.8x at closing and no financing conditions.
  6. Mott will join the Health & Science Technologies segment; company targets semiconductor wafer fab equipment, energy transition, medical technologies, space & defense and water purification markets.
  7. Expected closing by the end of the third quarter of 2024, subject to regulatory approvals and customary closing conditions.

Frequently Asked Questions

  1. How much is IDEX paying for Mott, and how is the price adjusted?

    IDEX is paying $1 billion in cash, subject to customary adjustments. Adjusted for the present value of expected tax benefits of approximately $100 million, the net transaction value is approximately $900 million.

  2. What does the valuation imply relative to Mott's earnings?

    The company states the price represents approximately 19x Mott's forecasted full year 2024 EBITDA and a mid-teens multiple based on forecasted 2025 EBITDA.

  3. How will the acquisition be financed?

    It will be funded through a combination of cash on hand, borrowings from IDEX's current credit facility, and potential debt issuance. The transaction is not subject to any financing conditions, and net leverage is expected to be approximately 1.8x at closing.

  4. When does IDEX expect the deal to contribute to earnings and returns?

    IDEX expects the transaction to be accretive to adjusted EPS in fiscal 2026 and to deliver a double-digit ROIC in year five after closing. The company also expects meaningful commercial and new product development synergies.

  5. When is the transaction expected to close?

    The transaction is expected to close by the end of the third quarter of 2024, subject to regulatory approvals and customary closing conditions.